Strides Arcolab Ltd has informed BSE regarding a Press Release dated August 26, 2014 titled "Strides Arcolab receives US FDA approval for Buspirone Tablets".
Strides Arcolab has received approval from United State Food & Drug Administration for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg.Source : BSE
Read all announcements in Strides Arcolab
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!